IDiyas

For the Inventor, By the Inventor

The patent badge is an abbreviated version of the USPTO patent document. The patent badge does contain a link to the full patent document.

The patent badge is an abbreviated version of the USPTO patent document. The patent badge covers the following: Patent number, Date patent was issued, Date patent was filed, Title of the patent, Applicant, Inventor, Assignee, Attorney firm, Primary examiner, Assistant examiner, CPCs, and Abstract. The patent badge does contain a link to the full patent document (in Adobe Acrobat format, aka pdf). To download or print any patent click here.

Patent No.:

US 10588914 B1

PDFFull Text
Date of Patent:
Mar. 17, 2020

Filed:

Jan. 08, 2019

Topical formulations comprising a steroid

Applicant:

Encore Dermatology, Inc., Malvern, PA (US);

Inventors:

Udhumansha Ubaidulla, Namakkal, IN;

Sateesh Kandavilli, Plainsboro, NJ (US);

Ajay Sunil Vairale, Hyderabad, IN;

Jeffrey A. Wayne, Markham, CA;

Vijendra Nalamothu, Basking Ridge, NJ (US);

Mistry Meghal, Ahmedabad, IN;

Refika Isil Pakunlu, Highland Park, NJ (US);

Assignee:

ENCORE DERMATOLOGY, INC., Malvern, PA (US);

Attorney:

Pepper Hamilton LLP

Primary Examiner:

Nannette Holloman

Int. Cl.
CPC ...
A61K 31/573 (2006.01); B05B 15/30 (2018.01); A61K 9/00 (2006.01); A61K 9/70 (2006.01); A61K 31/575 (2006.01); A61K 31/58 (2006.01); A61K 47/10 (2017.01); A61K 47/14 (2017.01); A61K 47/32 (2006.01); A61K 47/36 (2006.01); A61K 47/38 (2006.01); A61K 47/44 (2017.01); A61K 31/56 (2006.01); A61K 47/26 (2006.01); A61K 9/107 (2006.01); A61K 47/22 (2006.01); B05B 1/02 (2006.01); B05B 11/00 (2006.01); B05B 1/30 (2006.01);
U.S. Cl.
CPC ...
A61K 31/573 (2013.01); A61K 9/0014 (2013.01); A61K 9/107 (2013.01); A61K 9/7015 (2013.01); A61K 31/56 (2013.01); A61K 31/575 (2013.01); A61K 31/58 (2013.01); A61K 47/10 (2013.01); A61K 47/14 (2013.01); A61K 47/22 (2013.01); A61K 47/26 (2013.01); A61K 47/32 (2013.01); A61K 47/36 (2013.01); A61K 47/38 (2013.01); A61K 47/44 (2013.01); B05B 1/02 (2013.01); B05B 1/30 (2013.01); B05B 11/3045 (2013.01); B05B 15/30 (2018.02);
Abstract

The application provides formulations for the topical administration of an active agent comprising at least one steroid, in the form of topical sprays that are propellant-free, and/or substantially non-foaming, and/or alcohol-free. The present application also provides processes for preparing such compositions and methods of using them in management of skin diseases or disorders such as psoriasis, dermatoses, and other associated skin diseases or disorders.

Find Patent Forward Citations

Loading…